Mohs Micrographic Surgery for Periorbital Skin Cancer

Periocular Mohs micrographic surgery in Western Australia 2009–2012: A single centre retrospective review and proposal for practice benchmarks

“…Periocular skin tumours can be challenging to manage. The literature supports the benefits of a multidisciplinary approach between Mohs surgeons and oculoplastic surgeons …”

“…It has an evidence‐based, 5‐year cure rate up to 99% for primary basal cell carcinoma (BCC) and up to 94% for recurrent BCC . High cure rate along with maximal preservation of normal tissue are key considerations in the management of periocular tumours . Recurrence rate reported in the literature for non‐microscopically controlled surgical excision are in the range 5–100% and are related to underestimation of subclinical extension of BCC …”

Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. II. Reconstruction and follow‐up

“…Our recurrence rate can be compared with Mohs (1986), Leib et al (1992) and Monheit et al (1989), with a 2-7% recurrence within five years in similar high-risk tumours treated using Mohs micrographic technique. In comparison Sigurdsson and Agnarsson (1998) reported a 38% risk of recurrence for incompletely excised tumours.…”

Management of malignant and benign eyelid lesions

“…More recently, two new clinical entities of BCC have been reported: a nodular form with an infiltrative component that may extend beyond the clinically obvious margins and a linear form that seems to have more aggressive behaviour [9,10]. Mortality rate from ocular BCCs is estimated to be 3% and usually occurs secondarily to intracranial extension of tumors that have been inadequately treated or clinically neglected [11][12][13][14]. BCCs arising in the medial canthal region are at particular high risk for intraorbital and intracranial extension.…”